- NRx Pharmaceuticals (NASDAQ:NRXP) appoints extensive experienced in law, finance, and management of public and private biotechnology companies Stephen Willard as its CEO and a member of the company's board of directors.
- The company's interim CEO, Robert Besthof, will continue to support the company and return to his roles as Head of Operations and Chief Commercial Officer.
- Most recently, Mr. Willard served as CEO of Cellphire Therapeutics.
Recommended For You
More Trending News
See More »